Previous Article | Next Article 
Infection and Immunity, February 2005, p. 1217-1220, Vol. 73, No. 2
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.2.1217-1220.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Modulation of an Outer Membrane Protease Contributes to the Virulence Defect of Shigella flexneri Strains Carrying a Mutation in the virK Locus
Helen J. Wing ,
,
Seth R. Goldman,
Shabeen Ally, and
Marcia B. Goldberg*
Infectious Disease Division, Massachusetts General Hospital, Boston, Massachusetts
Received 9 July 2004/
Returned for modification 16 September 2004/
Accepted 20 October 2004

ABSTRACT
The
Shigella actin assembly protein IcsA is removed from the
bacterial surface by the protease IcsP. We show that decreased
intracellular spreading of
virK::Tn
10 mutants is due in part
to significant increases in IcsP and IcsP-mediated cleavage
of IcsA and that IcsP expression is a critical determinant of
Shigella virulence.

TEXT
Shigellae move through the cytoplasm of infected cells and into
adjacent cells by assembly of a propulsive actin tail (
1,
15,
16,
20,
22), mediated by the polar outer membrane protein IcsA
(VirG) (
1,
7,
8,
11,
15). The domain of IcsA that mediates actin
assembly is removed from the bacterial surface by the outer
membrane protease IcsP (SopA), releasing a truncated IcsA polypeptide
into the culture supernatant (
3,
23).
IcsP contributes to the intercellular spreading defect of virK transposon insertion mutants.
Strains that carry a transposon insertion in the poorly characterized gene virK display decreased levels of IcsA in total cellular protein preparations and decreased intercellular spreading but wild-type levels of icsA mRNA (18). We postulated that these phenotypes might be due to increased cleavage of IcsA by IcsP. Levels of truncated IcsA in the culture supernatant prepared from mid-exponential-phase cultures as previously described (2, 26) were reproducibly increased threefold or more in a virK mutant compared to those in the wild-type strain (Fig. 1A), indicating increased cleavage of IcsA from the surface of the mutant. Furthermore, IcsP levels (26) were reproducibly increased fivefold or more in the mutant compared to those in the wild-type, consistent with the increased cleavage of IcsA in the virK mutants being mediated by increased levels of IcsP. As for wild-type strains (3, 7, 23), in the virK mutant, IcsP fractionated to the outer membrane and IcsA was localized to the pole (data not shown). The IcsA and IcsP phenotypes were indistinguishable for each of three virK mutants (V836, V956, and V1060) (18); we selected V956 for the studies described below.
Introduction of the
icsP mutation into the
virK::Tn
10 mutant
by P1L4 transduction (
17) led to undetectable amounts of cleaved
IcsA in the culture supernatant and a greater than 20-fold increase
in full-length IcsA associated with the bacterial pellet (Fig.
1B). The increase in bacterium-associated IcsA of the double
mutant was comparable to that of the
icsP single mutant, indicating
that IcsP mediates essentially all of the increase in IcsA cleavage
in the
virK mutant. As reported previously (
3,
23), the level
of full-length IcsA associated with the bacterial pellet was
increased in the
icsP mutant compared to that in the wild type.
To determine whether IcsP is responsible for the defect in intercellular spreading of the virK mutant (18), we tested whether introduction of a disruption of icsP into the virK::Tn10 mutant would rescue the spreading phenotype of the virK::Tn10 mutant. The virK::Tn10 icsP double mutant generated a mixture of plaques that were larger than or approximately equal in size to those of the virK::Tn10 mutant (Fig. 1C; Table 1), demonstrating partial rescue of intercellular spreading and indicating that the small-plaque phenotype of the virK::Tn10 mutant is due at least in part to IcsP. As reported previously (3, 18, 23), the virK::Tn10 mutant formed very small plaques, some of which were only visible microscopically, and the icsP mutant formed plaques approximately the size of those formed by the wild-type strain. The total number of plaques, including those seen only microscopically, was comparable for all of the strains tested. These data indicate that both the decrease in bacterium-associated IcsA and the defect in actin-based motility of the virK mutant are mediated at least partially by the effect of the virK::Tn10 mutation on expression of IcsP and the resultant increase in IcsP-mediated cleavage of IcsA at the bacterial surface.
Overexpression of IcsP leads to decreased actin-based motility and decreased intercellular spreading.
To directly examine the effect of overexpression of IcsP on
intercellular spreading, we constructed a strain in which expression
of a plasmid-borne
icsP gene can be induced with isopropyl-ß-
D-thiogalactopyranoside
(IPTG) (strain SSA9, Table
2). With increasing concentrations
of IPTG, the amount of IcsP increased and the amount of IcsA
associated with the bacteria decreased (Fig.
2A), with no effect
on the growth rate (data not shown). Furthermore, with increasing
IPTG concentrations, actin tail assembly was progressively less
efficient (Fig.
2B). A small effect was seen even in the absence
of added IPTG, consistent with the known leakiness of the promoter.
In the presence of 0.01 or 0.025 mM IPTG, actin tails were infrequent
and when present were stunted; in the presence of 0.05 mM IPTG,
actin tails were almost completely absent and the bacteria formed
tight clusters in the cell, a phenotype seen with
icsA mutants
(
1) and consistent with a total absence of actin-based motility.
Intercellular spreading, as measured by the presence and size
of bacterial plaques on a cell monolayer (
19), was impaired
in a similar manner (Fig.
2C; Table
3), whereas bacterial entry
was unaffected (data not shown). IPTG alone had no effect on
the actin tail formation, intercellular spreading, or IcsP levels
of the wild-type strain (Fig.
2; Table
3). Thus, artificially
increasing the level of IcsP leads to marked defects in actin
assembly, indicating that IcsP is an important determinant of
Shigella virulence.
We speculate that the effect of the
virK::Tn
10 mutation on IcsP
may reflect alteration of interactions in the outer membrane
between lipopolysaccharide (LPS) and IcsP, which likely binds
LPS. First, although the precise function of
virK has not been
determined, its genetic context within the locus
shf-
rfbU-
virK-
msbB2 suggests that it may be involved in LPS modification. Whereas
the function of
shf is unknown (
29),
rfbU and
msbB2 each modify
LPS (
4,
9). Second, although complementation of the IcsA and
intercellular spreading phenotypes of a
virK::Tn
10 mutant by
virK without
msbB2 (
18) implicates
virK in these phenotypes,
it does not eliminate the possibility that both
virK and
msbB2 are involved.
Third, IcsP is a member of the omptin family of outer membrane proteases (25), which includes PgtE of Salmonella enterica serovar Typhimurium (30), Pla of Yersinia pestis (24), and OmpT (27) and OmpP (10) of Escherichia coli. Five of 11 residues involved in LPS binding by the outer membrane protein FhuA (5, 6) are conserved in OmpT, including 3 that interact with lipid A (28). Four of these five are also conserved in IcsP (M. B. Goldberg, unpublished data) and in other members of the omptin family (13). Moreover, the in vitro activity of OmpT is increased in the presence of LPS (12). Therefore, structural changes in lipid A that occur with mutation of msbB2 and perhaps virK::Tn10 may alter an interaction of lipid A with IcsP, which in turn may alter its stability or activity. These issues are the subject of ongoing investigation.

ACKNOWLEDGMENTS
We thank C. Sasakawa for generously providing strains YSH6000T,
V836, V956, and V1060.
This work was supported by Public Health Service grants AI43562 and AI35817 from the National Institute of Allergy and Infectious Diseases (M.B.G.), a Charles H. Hood Foundation (Boston, Mass.) postdoctoral research fellowship from The Medical Foundation (H.J.W.), and a Massachusetts General Hospital Fund for Medical Discovery postdoctoral fellowship (H.J.W.).

FOOTNOTES
* Corresponding author. Mailing address: Bacterial Pathogenesis Laboratories, University Park, 65 Landsdowne St., Cambridge, MA 02139. Phone: (617) 768-8740. Fax: (617) 768-8738. E-mail:
mgoldberg1{at}partners.org.

Editor: J. N. Weiser
H.J.W. and S.R.G. contributed equally to this work. 
Present
address: Department of Biological Sciences, University of
Nevada-Las Vegas, Las Vegas. 

REFERENCES
1 - Bernardini, M. L., J. Mounier, H. d'Hauteville, M. Coquis-Rondon, and P. J. Sansonetti. 1989. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin. Proc. Natl. Acad. Sci. USA 86:3867-3871.[Abstract/Free Full Text]
2 - Caldwell, R. B., and C. T. Lattemann. 2004. Simple and reliable method to precipitate proteins from bacterial culture supernatant. Appl. Environ. Microbiol. 70:610-612.[Abstract/Free Full Text]
3 - Egile, C., H. d'Hauteville, C. Parsot, and P. J. Sansonetti. 1997. SopA, the outer membrane protease responsible for polar localization of IcsA in Shigella flexneri. Mol. Microbiol. 23:1063-1073.[CrossRef][Medline]
4 - Fallarino, A., C. Mavrangelos, U. H. Stroeher, and P. A. Manning. 1997. Identification of additional genes required for O-antigen biosynthesis in Vibrio cholerae O1. J. Bacteriol. 179:2147-2153.[Abstract/Free Full Text]
5 - Ferguson, A. D., E. Hofmann, J. W. Coulton, K. Diederichs, and W. Welte. 1998. Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science 282:2215-2220.[Abstract/Free Full Text]
6 - Ferguson, A. D., W. Welte, E. Hofmann, B. Lindner, O. Holst, J. W. Coulton, and K. Diederichs. 2000. A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins. Struct. Fold Des. 8:585-592.[Medline]
7 - Goldberg, M. B., O. Barzu, C. Parsot, and P. J. Sansonetti. 1993. Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. J. Bacteriol. 175:2189-2196.[Abstract/Free Full Text]
8 - Goldberg, M. B., and J. A. Theriot. 1995. Shigella flexneri surface protein IcsA is sufficient to direct actin-based motility. Proc. Natl. Acad. Sci. USA 92:6572-6576.[Abstract/Free Full Text]
9 - Kaniuk, N. A., E. Vinogradov, J. Li, M. A. Monteiro, and C. Whitfield. 2004. Chromosomal and plasmid-encoded enzymes are required for assembly of the R3-type core oligosaccharide in the lipopolysaccharide of Escherichia coli O157:H7. J. Biol. Chem. 279:31237-31250.[Abstract/Free Full Text]
10 - Kaufmann, A., Y. D. Stierhof, and U. Henning. 1994. New outer membrane-associated protease of Escherichia coli K-12. J. Bacteriol. 176:359-367.[Abstract/Free Full Text]
11 - Kocks, C., J.-B. Marchand, E. Gouin, H. d'Hauteville, P. J. Sansonetti, M.-F. Carlier, and P. Cossart. 1995. The unrelated surface proteins ActA of Listeria monocytogenes and IcsA of Shigella flexneri are sufficient to confer actin-based motility on Listeria innocua and Escherichia coli, respectively. Mol. Microbiol. 18:413-423.[CrossRef][Medline]
12 - Kramer, R. A., K. Brandenburg, L. Vandeputte-Rutten, M. Werkhoven, P. Gros, N. Dekker, and M. R. Egmond. 2002. Lipopolysaccharide regions involved in the activation of Escherichia coli outer membrane protease OmpT. Eur. J. Biochem. 269:1746-1752.[Medline]
13 - Kukkonen, M., M. Suomalainen, P. Kyllonen, K. Lahteenmaki, H. Lang, R. Virkola, I. M. Helander, O. Holst, and T. K. Korhonen. 2004. Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica. Mol. Microbiol. 51:215-225.[CrossRef][Medline]
14 - LaBrec, E. H., H. Schneider, T. J. Magnani, and S. B. Formal. 1964. Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery. J. Bacteriol. 88:1503-1518.[Abstract/Free Full Text]
15 - Lett, M.-C., C. Sasakawa, N. Okada, T. Sakai, S. Makino, M. Yamada, K. Komatsu, and M. Yoshikawa. 1989. virG, a plasmid-coded virulence gene of Shigella flexneri: identification of the virG protein and determination of the complete coding sequence. J. Bacteriol. 171:353-359.[Abstract/Free Full Text]
16 - Makino, S., C. Sasakawa, K. Kamata, T. Kurata, and M. Yoshikawa. 1986. A genetic determinant required for continuous reinfection of adjacent cells on large plasmid in S. flexneri 2a. Cell 46:551-555.[CrossRef][Medline]
17 - Maurelli, A. T., and R. Curtiss, 3rd. 1984. Bacteriophage Mu d1(Apr lac) generates vir-lac operon fusions in Shigella flexneri 2a. Infect. Immun. 45:642-648.[Abstract/Free Full Text]
18 - Nakata, N., C. Sasakawa, N. Okada, T. Tobe, I. Fukuda, T. Suzuki, K. Komatsu, and M. Yoshikawa. 1992. Identification and characterization of virK, a virulence-associated large plasmid gene essential for intercellular spreading of Shigella flexneri. Mol. Microbiol. 6:2387-2395.[Medline]
19 - Oaks, E. V., M. E. Wingfield, and S. B. Formal. 1985. Plaque formation by virulent Shigella flexneri. Infect. Immun. 48:124-129.[Abstract/Free Full Text]
20 - Ogawa, H., A. Nakamura, and R. Nakaya. 1968. Cinemicrographic study of tissue cell cultures infected with Shigella flexneri. Jpn. J. Med. Sci. Biol. 21:259-273.[Medline]
21 - Okada, N., C. Sasakawa, T. Tobe, K. A. Talukder, K. Komatsu, and M. Yoshikawa. 1991. Construction of a physical map of the chromosome of Shigella flexneri 2a and the direct assignment of nine virulence-associated loci identified by Tn5 insertions. Mol. Microbiol. 5:2171-2180.[Medline]
22 - Pal, T., J. W. Newland, B. D. Tall, S. B. Formal, and T. L. Hale. 1989. Intracellular spread of Shigella flexneri associated with the kcpA locus and a 140-kilodalton protein. Infect. Immun. 57:477-486.[Abstract/Free Full Text]
23 - Shere, K. D., S. Sallustio, A. Manessis, T. G. D'Aversa, and M. B. Goldberg. 1997. Disruption of IcsP, the major Shigella protease that cleaves IcsA, accelerates actin-based motility. Mol. Microbiol. 25:451-462.[CrossRef][Medline]
24 - Sodeinde, O. A., and J. D. Goguen. 1989. Nucleotide sequence of the plasminogen activator gene of Yersinia pestis: relationship to ompT of Escherichia coli and gene E of Salmonella typhimurium. Infect. Immun. 57:1517-1523.[Abstract/Free Full Text]
25 - Stathopoulos, C. 1998. Structural features, physiological roles, and biotechnological applications of the membrane proteases of the OmpT bacterial endopeptidase family: a micro-review. Membr. Cell Biol. 12:1-8.[Medline]
26 - Steinhauer, J., R. Agha, T. Pham, A. W. Varga, and M. B. Goldberg. 1999. The unipolar Shigella surface protein IcsA is directly targeted to the old pole; IcsP cleavage of IcsA occurs over the entire bacterial surface. Mol. Microbiol. 32:367-378.[CrossRef][Medline]
27 - Sugimura, K., and T. Nishihara. 1988. Purification, characterization, and primary structure of Escherichia coli protease VII with specificity for paired basic residues: identity of protease VII and OmpT. J. Bacteriol. 170:5625-5632.[Abstract/Free Full Text]
28 - Vandeputte-Rutten, L., R. A. Kramer, J. Kroon, N. Dekker, M. R. Egmond, and P. Gros. 2001. Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site. EMBO J. 20:5033-5039.[CrossRef][Medline]
29 - Venkatesan, M. M., M. B. Goldberg, D. J. Rose, E. J. Grotbeck, V. Burland, and F. R. Blattner. 2001. Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri. Infect. Immun. 69:3271-3285.[Abstract/Free Full Text]
30 - Yu, G. Q., and J. S. Hong. 1986. Identification and nucleotide sequence of the activator gene of the externally induced phosphoglycerate transport system of Salmonella typhimurium. Gene 45:51-57.[CrossRef][Medline]
Infection and Immunity, February 2005, p. 1217-1220, Vol. 73, No. 2
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.2.1217-1220.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.